- Home
- GNTX vs MANE Comparison
GNTX vs MANE Comparison
Compare GNTX & MANE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | GNTX | MANE |
|---|---|---|
| Founded | 1974 | 2019 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Auto Parts:O.E.M. | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.4B | 4.3B |
| IPO Year | 1995 | 2026 |
Fundamental Metrics
Financial Performance| Metric | GNTX | MANE |
|---|---|---|
| Price | $20.07 | $133.52 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | $25.28 | ★ $170.50 |
| AVG Volume (30 Days) | ★ 3.1M | 773.7K |
| Earning Date | 10-23-2026 | 11-17-2026 |
| Dividend Yield | ★ 2.33% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ 1.00 | N/A |
| Revenue | ★ $2,534,268,965.00 | N/A |
| Revenue This Year | $3.94 | N/A |
| Revenue Next Year | $6.28 | N/A |
| P/E Ratio | $20.48 | ★ N/A |
| Revenue Growth | ★ 9.55 | N/A |
| 52 Week Low | $19.75 | $35.43 |
| 52 Week High | $26.48 | $146.58 |
Technical Indicators
Market Signals| Indicator | GNTX | MANE |
|---|---|---|
| Relative Strength Index (RSI) | 41.74 | 57.33 |
| Support Level | N/A | $92.62 |
| Resistance Level | $22.25 | N/A |
| Average True Range (ATR) | 0.55 | 7.89 |
| MACD | -0.00 | 0.03 |
| Stochastic Oscillator | 27.20 | 73.83 |
Price Performance
Historical ComparisonAbout GNTX Gentex Corporation
Gentex was founded in 1974 to produce smoke-detection equipment. The company sold its first glare-control interior mirror in 1982 and its first model using electrochromic technology in 1987. Automotive revenue was about 89% of total revenue in 2025, down from 98% in 2024 due to the Voxx acquisition in April 2025. The company is constantly developing new applications for the technology to remain on top. Sales in 2025 totaled about $2.5 billion with 44.8 million mirrors shipped. The unit mix breaks out as 64% interior and 36% exterior versus 31% exterior in 2019. The company is based in Zeeland, Michigan.
About MANE Veradermics Incorporated Common Stock
Veradermics Inc clinical-stage biopharmaceutical company focused on developing therapeutics to address pervasive treatment challenges in prevalent aesthetic and dermatological conditions. The company operates in a single segment of allocating resources, assessing performance, and making operating decisions.